✦ LIBER ✦

LIPOXYGENASE INHIBITORS INDUCE DEATH RECEPTOR 5/TRAIL-R2 EXPRESSION AND SENSITIZE THE DU145 HUMAN PROSTATE CANCER CELL LINE TO TRAIL-INDUCED APOPTOSIS

✍ Scribed by Shiraishi, Takumi; Yoshida, Tatsushi; Yasuda, Takashi; Nakamura, Terukazu; Mikami, Kazuya; Takaha, Natsuki; Horinaka, Mano; Nakata, Susumu; Goda, Ahmed E; Nishikawa, Akiyoshi; Mizutani, Yoichi; Kawauchi, Akihiro; Sakai, Toshiyuki; Miki, Tsuneharu

Book ID: 123333832
Publisher: Lippincott Williams and Wilkins
Year: 2008
Tongue: English
Weight: 171 KB
Volume: 179
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(08)61137-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lipoxygenase inhibitors induce death rec

Lipoxygenase inhibitors induce death receptor 5/TRAIL-R2 expression and sensitize malignant tumor cells to TRAIL-induced apoptosis

✍ Tatsushi Yoshida; Takumi Shiraishi; Mano Horinaka; Susumu Nakata; Takashi Yasuda 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB

Histone deacetylase inhibitors upregulat

Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells

✍ Nakata, Susumu; Yoshida, Tatsushi; Horinaka, Mano; Shiraishi, Takumi; Wakada, Mi 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 556 KB

Low concentrations of doxorubicin sensit

Low concentrations of doxorubicin sensitizes human solid cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-receptor (R) 2-mediated apoptosis by inducing TRAIL-R2 expression

✍ Xiu-Xian Wu; Xing-Hua Jin; Yu Zeng; Ahmed Mamdouh Abd El Hamed; Yoshiyuki Kakehi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 628 KB

Naringenin up-regulates the expression o

Naringenin up-regulates the expression of death receptor 5 and enhances TRAIL-induced apoptosis in human lung cancer A549 cells

✍ Cheng-Yun Jin; Cheol Park; Hye Jin Hwang; Gi-Young Kim; Byung Tae Choi; Wun-Jae 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 365 KB

While TRAIL is relatively non-toxic to normal cells, it can selectively induce apoptosis in many types of transformed cells. Nevertheless, some non-small cell lung cancer (NSCLC) cells are particularly resistant to the effects of TRAIL. Here, we report that in combination with naringenin exposure to

Activity of selective fully human agonis

Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell death

✍ Georgios V. Georgakis; Yang Li; Robin Humphreys; Michael Andreeff; Susan O'Brien 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 487 KB